Inside a bigger box

Valentis Inc., which has been pursuing a path of acquisition to achieve critical mass in biologics delivery, believes that the key to its success is not so much thinking outside the box, but putting a number of boxes together to build a bigger box.

VLTS itself was created through the merger of